Jun Mou

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.

A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients.

Journal: Frontiers in immunology

Published: May 31, 2025

Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure mice.

Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure mice.

Journal: Frontiers in immunology

Published: May 08, 2025

Compounds from Cyclocarya paliurus leaves inhibit binary division of methicillin-resistant Staphylococcus aureus by disrupting FtsZ dynamic.

Compounds from Cyclocarya paliurus leaves inhibit binary division of methicillin-resistant Staphylococcus aureus by disrupting FtsZ dynamic.

Journal: Frontiers in microbiology

Published: May 04, 2025

Knowledge-guided diffusion model for 3D ligand-pharmacophore mapping.

Knowledge-guided diffusion model for 3D ligand-pharmacophore mapping.

Journal: Nature communications

Published: August 23, 2024

X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model.

X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model.

Journal: Journal of medicinal chemistry

Published: May 31, 2024

Recombinant protein Ag85B-Rv2660c-MPT70 promotes quality of BCG-induced immune response against Mycobacterium tuberculosis H37Ra.

Recombinant protein Ag85B-Rv2660c-MPT70 promotes quality of BCG-induced immune response against Mycobacterium tuberculosis H37Ra.

Journal: Frontiers in immunology

Published: May 10, 2024

Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG.

Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 23, 2024

Hypoxia-inducible factor 2α promotes pathogenic polarization of stem-like Th2 cells via modulation of phospholipid metabolism.

Hypoxia-inducible factor 2α promotes pathogenic polarization of stem-like Th2 cells via modulation of phospholipid metabolism.

Journal: Immunity

Published: March 10, 2023

Water bath is more efficient than hot air oven at thermal inactivation of coronavirus.

Water bath is more efficient than hot air oven at thermal inactivation of coronavirus.

Journal: Virology journal

Published: February 08, 2023

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma.

Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma.

Journal: Frontiers in cell and developmental biology

Published: April 01, 2021

Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions.

Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: November 25, 2020

Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.

Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization.

Journal: Cell death & disease

Published: September 03, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026